shifting the treatment landscape of itp: novel agents and future outlooks
Published 1 year ago • 357 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
1:06
how will novel agents & car-t cells affect the future treatment landscape in b-all?
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
0:48
novel off-the-shelf cars: where may these agents fit in the hemonc treatment landscape?
-
0:52
rilzabrutinib: a novel promising btk inhibitor being explored in itp
-
1:06:04
itp: novel treatments
-
4:49
myelofibrosis - causes, symptoms, diagnosis, treatment, pathology
-
17:49
trump inauguration speech (full) | abc news
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy
-
2:04
future directions in mpn therapy
-
3:47
update on the guidelines for the diagnosis, grading & management of icaht following car-t therapy
-
1:29
new hnhcp car-t therapy guidelines: an educational resource for nurses and hcps
-
1:30
addressing unmet needs in myelofibrosis: alleviating anemia
-
5:09
the evolving role of nurses in the field of car-t
-
1:23
moving car-t therapy to the outpatient setting
-
1:03
delivering hope via transformational research
-
5:31
adjusting to a shifting healthcare landscape
-
1:15
exciting updates in cll and the importance of immune characterization
-
1:22
a cost-effective simulation model for ccc - supplementary video 1 [id 378298]